Neuropsychopharmacology
- BDNF in ventrolateral orbitofrontal cortex to dorsolateral striatum circuit moderates alcohol consumption, seeking and relapse7 months ago
- Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia7 months ago
- Single-cell RNA sequencing uncovers molecular features underlying microglial lipid accumulation and depression-related behaviors in high-fat diet mouse model of obesity7 months ago
- Pre-trauma cognitive traits predict fear generalization and associated prefrontal functioning in a longitudinal rodent model7 months ago
- Trajectories of mental health and mental illness: where we are now and where we go next7 months ago
- Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects7 months ago
- Integrating multi-polygenic scores for enhanced prediction of antidepressant treatment outcomes in an East Asian population7 months ago
Journal of Psychopharmacology
- A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy12 months ago
- Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder12 months ago
- Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression – comparison with ketamine, fluoxetine and lithium1 year ago
- What are set and setting: Reducing vagueness to improve research and clinical practice1 year ago
- Centrally-acting opioid receptor antagonists as a treatment for antipsychotic-induced weight gain: A systematic review and meta-analysis of clinical trial data1 year ago
- Psychedelic-assisted psychotherapy: The need to monitor adverse events1 year ago
- Mapping acute alcohol effects on bodily sensations: A cross-dimensional interoceptive approach1 year ago
European Neuropsychopharmacology
- Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study1 year ago
- Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to “Muscle and the mind: The combination of creatine and exercise for depression?”1 year ago
- Longitudinal brain age in first-episode mania youth treated with lithium or quetiapine1 year ago
- Egr2 Modulation in the Medial Prefrontal Cortex Regulates Resistance to Stress-Induced Memory Impairments1 year ago
- Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov1 year ago
- Creatine as a treatment for depression: A brain bioenergetics perspective1 year ago
- Rethinking suicide prediction: From static risk factors to dynamic models1 year ago